The effect of COVID-19 on nuclear medicine and radiopharmacy activities: A global survey-Reference-Cited by-同舟云学术

The effect of COVID-19 on nuclear medicine and radiopharmacy activities: A global survey

Published:2023-06-28 Issue:1 Volume:13 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Al-Saeedi Fatma,Rajendran Peramaiyan,Tipre Dnyanesh,Aladwani Hassan,Alenezi Salem,Alqabandi Maryam,Alkhamis Abdullah,Redha Abdulmohsen,Mohammad Ahmed,Ahmad Fahad,Abdulnabi Yaaqoup,Alfadhly Altaf,Alrasheedi Danah

Abstract

AbstractGlobally, COVID-19 affected radiopharmaceutical laboratories. This study sought to determine the economic, service, and research impacts of COVID-19 on radiopharmacy. This online survey was conducted with the participation of employees from nuclear medicine and radiopharmaceutical companies. The socioeconomic status of the individuals was collected. The study was participated by 145 medical professionals from 25 different countries. From this work, it is evident that 2-deoxy-2-[18F]fluoro-D-glucose (2-[18F]FDG), and 99mTc-labeled macro aggregated albumin 99mTc-MAA were necessary radiopharmaceuticals used by 57% (83/145and 34% (49/145;) respondents, respectively for determining how COVID infections affect a patient’s body. The normal scheduling procedure for the radiopharmacy laboratory was reduced by more than half (65%; 94/145). In COVID-19, 70% (102/145) of respondents followed the regulations established by the local departments. Throughout the pandemic, there was a 97% (141/145) decrease in all staffing recruitment efforts. The field of nuclear medicine research, as well as the radiopharmaceutical industry, were both adversely affected by COVID-19.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/s41598-023-36925-4.pdf

Reference45 articles.

1. Chen, Y. et al. Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care 43, 1399–1407. https://doi.org/10.2337/dc20-0660 (2020).

2. Huang, Y., Chen, D., Fietze, I. & Penzel, T. Obstructive sleep apnea with COVID-19. Adv. Exp. Med. Biol. 1384, 281–293. https://doi.org/10.1007/978-3-031-06413-5_17 (2022).

3. Wang, C., Havewala, M. & Zhu, Q. COVID-19 stressful life events and mental health: Personality and coping styles as moderators. J. Am. Coll. Health https://doi.org/10.1080/07448481.2022.2066977 (2022).

4. Gao, Q. et al. Perceived stress and stress responses during COVID-19: The multiple mediating roles of coping style and resilience. PLoS One 17, e0279071. https://doi.org/10.1371/journal.pone.0279071 (2022).

5. Xu, S. et al. Impact of the COVID-19 on electricity consumption of open university campus buildings—The case of Twente University in the Netherlands. Energy Build 279, 112723. https://doi.org/10.1016/j.enbuild.2022.112723 (2023).